• Commissioning mental health services in primary care

    16 October 2017

    A report by NHS Clinical Commissioners showcases programmes that are embedding mental health services in primary care and draws out advice from the commissioners and practitioners involved in their development and delivery. It highlights projects where CCGs and their partners are delivering better care for patients, working across the boundaries between services and reducing pressure on GPs and hospitals.

    Read More
  • New guidance on dementia-friendly dentistry

    16 October 2017

    The Faculty of General Dental Practice UK has published new guidance on the practice of dentistry for patients with dementia.

    With around 850,000 people in the UK with dementia - 5% of the population - the faculty says that dental professionals need to understand the condition, and adapt their patient management and clinical decisions accordingly.

    Read More
  • Quality payments scheme - guidance for the November declaration

    16 October 2017

    NHS England has published further guidance for pharmacy contractors taking part in the quality payments scheme. This should be read in conjunction with the two previously published guidance documents. The guidance clarifies the requirements for meeting the gateway and quality criteria, completing the November declaration process and providing evidence for the validation procedures.

    Read More
  • Groin hernia and varicose vein surgery removed from patient reported outcome measures

    16 October 2017

    Changes are being made to the list of elective surgeries covered by patient reported outcome measures, the “before and after” research to measure how much patients feel they have benefited from their operation. PROMs for groin hernia and varicose vein operations are being phased out from 1 October 2017, but measures for hips and knee procedures will remain.

    Read More
  • Nominations for the national tariff high cost drugs and devices lists

    16 October 2017

    A number of high cost drugs and devices are paid for over and above the national tariff price for the related service. These drugs and devices appear on a high cost list which is part of the national tariff for 2017 to 2019. NHS England has opened a high cost drugs and devices survey for anyone to nominate drugs and devices to be added to, or removed from, the high cost lists for the next national tariff, due to take effect in April 2019. The closing date for nominations is 17 November 2017.

    Read More

Pages